A data engineer from Sydney used AI to design what may be the world's first personalized mRNA cancer vaccine for a dog.
Success with agents starts with embedding them in workflows, not letting them run amok. Context, skills, models, and tools are key. There’s more.
Researchers at the U.S. Army Combat Capabilities Development Command, or DEVCOM, Army Research Laboratory harnessed bottom-up Soldier innovation to develop an experimental 3D-printed small unmanned ...
A life sciences startup led by a former Spark Therapeutics researcher is raising funding to move a rheumatoid arthritis therapy toward clinical trials.
Understand the impact of AI coding on scientific workflows and how it can make computational tools more accessible to ...
Neo4j Aura Agent is an end-to-end platform for creating agents, connecting them to knowledge graphs, and deploying to ...
A recent Miami OpenClaw event with a 500-person waitlist revealed how eager business leaders are to deploy OpenClaw. How ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
The 2026 NCAA Tournament brackets have been revealed for the men and women, setting the stage for one of the most exciting months in sports. The first round of the men's March Madness bracket begins ...
UCSF scientists found a precise way to turn on cancer-fighting immune cells inside the body. This more potent form of CAR-T has the potential to treat many more cancers.
A combination cannabis cultivator, processor, shipper and retailer backed by Swervo Development Corp. is planned for a 50,000-square-foot property in Blaine.
Beyond seizures: With experimental drug, Stoke aims to restore developmental loss in Dravet syndrome
Stoke Therapeutics is developing a drug designed to reduce seizures and restore some of their lost developmental function.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results